Eli Lilly’s direct drug sales alone may not upend the industry, but others could follow suit

[ad_1] Sopa Images | Lightrocket | Getty Images Eli Lilly is shaking up the pharmaceutical industry with a new website offering telehealth prescriptions and direct home delivery of certain drugs,…

Patients regain weight after stopping Eli Lilly’s Zepbound, study says

[ad_1] Eli Lilly’s drug tirzepatide was approved for weight loss by the FDA. Courtesy of Eli Lilly Patients who took Eli Lilly‘s weight loss drug Zepbound regained around half the…

FDA approves Eli Lilly’s tirzepatide for weight loss, paving way for wider use of blockbuster drug

[ad_1] A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, on March…

Lilly’s diabetes drug gains backing of UK watchdog -Bloomberg News

[ad_1] The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg, France,…

Aspen to Start Distributing Lilly’s Blockbuster Diabetes Drug

[ad_1] The head of Aspen Pharmacare Holdings Ltd. said South Africans may get access to Eli Lilly & Co.’s blockbuster diabetes drug Mounjaro from next year in a coup for…

Europe to face shortage of Lilly’s diabetes drug through September

[ad_1] Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File photo Acquire Licensing Rights Aug 28 (Reuters) –…

Eli Lilly’s ‘triple G’ anti-obesity drug leads to 24% weight loss in trial

[ad_1] An experimental drug Retatrutide, also called “triple G”, has helped patients with obesity lose an average of 24 per cent of body weight on the highest dosage over 48…

Lilly’s Alzheimer’s success, a milestone FDA approval, & Moderna’s shrinking business

[ad_1] What’s the future of Alzheimer’s disease treatment? How do you pivot from a pandemic? And how successful can Wegovy get? We cover all that and more this week on…

Eli Lilly’s Insulin Decision Puts Others in Hot Seat

[ad_1] The drugmaker’s plan moves the spotlight to industry middlemen, who face a barrage of investigations. [ad_2] Source link

FDA Seeks More Data on Lilly’s Alzheimer’s Drug Candidate

[ad_1] Business Health Care Health Setback could delay potential commercial introduction by at least several months [ad_2] Source link